• Principal investigator (UBC) for the Children's Oncology Group (COG) for the conduct of clinical trials for children with pediatric malignancies
• Chairman of the Nutritional Committee for the COG, which develops nutritional clinical and translational research and intervention studies for children with malignancies
• Assessment of long-term sequelae in children with malignancies
  Clinical trials to improve treatments for childhood cancer
• Assessment of nutritional support for children with cancer
• Establish registry of haematological disorders in children with Down's Syndrome

•  Phase III Clinical Trials – Children’s Oncology Group

•  Nutrition Intervention: Supportive Care

•  Health Care Utilization of Long Term Pediatric Cancer Survivors

MacArthur AM, Spinelli JJ, Rogers PC, Goddard KJ, Abanto Z, McBride M.  Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada. Pediatr Blood Cancer. 2006 June 9; Epub ahead of print.

MacArthur AM, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride M. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer. 2006 June 9; Epub ahead of print.

Reebye Stacy C, Blair Geoffrey K, Rogers Paul C, Jamieson Douglas, Skarsgard Erik D.  An audit of cancer diagnosis in a Canadian children's hospital: Quality, timing and efficiency. Paediatric & Childhealth. Vol. 11, No. 3, March 2006.
 
Ladas E, Sacks N, Brophy P, Rogers PC. Standards of Nutritional Care in Pediatric Oncology: Results from a nationwide survey on the standards of practice in pediatric oncology. Pediatric Blood & Cancer. 46(3): 339-344, 2006.

Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ. Review: Obesity in Pediatric Oncology. Pediatr Blood Cancer 45:881-891, 2005.
 
Ladas EJ, Sacks N, Meacham l, Henry D, Enriques L, Lowry G, Hawkes R, Dadd G, Rogers P. A Multidisciplinary Review of Nutrition Considerations in the Pediatric Oncology Population: A Perspective From Children's Oncology Group. Nutrition in Clinical Practice 20:377-393, 2005.

Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescoria F, Davis MM, London WB, Lauer Sj, Giller RH, Cushing B; Pediatric Oncology Group 9048; Children's Cancer Group 8891. Treatment of children and adolescents with Stage II testicular and Stages I and II ovarian malignant germ cell tumours: A Pediatric Intergroup Study - Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol Sep 1;22(17):3563-9, 2004.
 
Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescoria F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049; Children's Cancer Group 8882. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors; a pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol Jul 1;22(13):2691-700, 2004.
 
McCahon E, Sorensen PH, Davis JH, Rogers PC, Schultz KR. Non-resectable congenital tumours with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol. May;40(5):288-92, 2003.
 
McCahon E, Tang K, Rogers PC, McBride ML, Schultz KR. The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children. Br J Haematol. Apr 121(1);170-2, 2003.

Colleen Fitzgerald - Clinical research manager
Dr. Elaine Peddie - Clinical assistant

Clinical research associates
Nita Takeuchi
Martina Javerina Barbour
Mary-Joan Galvez
Leijla Gavranovic
Joanne Shinde
Buffy Clague

Fellows
Dr. Geoff Cuvelier
Dr. Lisa Goodyear
Dr. Greg Guilcher
Dr. Ewa Lunaczel-Motyka
Dr. Rod Rassekh
Dr. Amanda Turnbull
Dr. Mark Winstanley
Dr. Rebecca Deyell